| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.28 | 0.006 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.095 | 0.007 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.007 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.007 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.007 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.007 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.15 | 0.008 |